Navigation Links
Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study
Date:8/10/2011

WEDNESDAY, Aug. 10 (HealthDay News) -- The breast cancer drug Herceptin increases the risk of heart problems in elderly patients, especially those with a history of heart disease and/or diabetes, a new study says.

Researchers analyzed the medical records of 45 women, ages 70 to 92, who were treated with Herceptin (trastuzumab) since 2005 and found that 12 (26.7 percent) of them developed heart problems caused by the drug.

That rate is slightly higher than what was noted in earlier clinical trials of younger, healthier women.

In this new study, 33 percent of the women with a history of heart disease developed either asymptomatic or symptomatic heart problems as a result of taking Herceptin, compared with 9.1 percent of women without a history of heart disease.

The researchers also found that about 33 percent of women with diabetes developed heart problems, compared with 6 percent of diabetes-free women.

When the women with heart problems stopped taking Herceptin, all but one recovered fully and five were able to re-start treatment with the drug.

The study appears in the journal Annals of Oncology.

"This is the first study specifically to assess trastuzumab-related cardiac toxicity and the cardiovascular factors that are associated with an increased risk in a selected population of elderly breast cancer patients," study author Dr. Cesar Serrano, who conducted the research while working as a clinical fellow at the Department of Medical Oncology Breast Cancer Centre at the Vall d'Hebron University Hospital in Barcelona, Spain, said in a journal news release.

"Trastuzumab is generally well-tolerated and, although there are some concerns about it causing heart problems, until now few risk factors have been identified among patients in clinical trials, most of whom are usually younger than 70 years and have good general health. Our study has demonstrated a significantly increased incidence of cardiac events among patients aged 70 and over with cardiovascular risk factors such as a history of cardiac disease and diabetes," said Serrano, who is now a postdoctoral research fellow at Brigham and Women's Hospital in Boston.

Serrano said the findings suggest that elderly women with one or more heart risk factors who are being treated with trastuzumab should be referred to a cardiologist. He also recommended closer monitoring of such patients for possible heart problems.

More information

The U.S. National Cancer Institute has more about breast cancer treatment.

-- Robert Preidt

SOURCE: Annals of Oncology, news release, Aug. 9, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Counseling May Help Women at Risk for Breast Cancer Gene
2. Research links diet during pregnancy to breast cancer risk reduction in female offspring
3. Fighting breast cancer from new angles
4. Research explores how breast cancer spreads and new ways to treat it
5. Progress made in understanding breast cancer risk
6. Support for Breast-Feeding Found Lacking in Many U.S. Hospitals
7. Leukemia drug reverses tamoxifen-resistance in breast cancer cells
8. ACR and SBI issue statement on British Medical Journal article on effect of mammography on breast cancer death rates
9. Drop in Breast Cancer Death Rates May Not Be Linked to Screening Rates
10. Tamoxifen Wards Off Breast Cancers Return for More Than a Decade
11. Popular mammography tool not effective for finding invasive breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study
(Date:2/26/2017)... ... ... The February 13, 2017, assassination of Kim Jong-nam, the half brother of North ... use of chemical weapons. Many questions exist about the effect that nerve agents can ... , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of the United ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC Baby Products, an innovative ... it would be offering some it’s exclusive product line to the public through ... unique baby clothing/feeding products, will team up with AMAZON to distribute a limited ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging ... according to a study released today at the 1st Pan American Parkinson’s and ... proven to be effective in improving cognitive function in PD patients. This study, ...
(Date:2/24/2017)... ... 2017 , ... Houston dentist , Dr. Behzad Nazari, ... Center. Currently, patients can get single dental implants for $3,599 and All On ... more about these offers by contacting Antoine Dental Center. Both of these options ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... provost of Liberty University, has officially announced the appointment of Peter A. Bell, ... College of Osteopathic Medicine (LUCOM), beginning April 10. Dr. Bell comes to ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... NEW YORK , February 27, 2017 ... (PII) celebrates the pharmaceutical companies that are most successful at ... ... question: if you gave the same molecule to two different ... it? Based on systematic, objective analysis of each ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
(Date:2/27/2017)... 27, 2017 The Dutch secure ... for use at the security level RESTRICTED. The solution thus ... organization for the communication of classified information. ... Sectra and Samsung have ... eavesdrop-secure smartphone solution. Sectra Tiger/R is developed by Sectra under ...
Breaking Medicine Technology: